Our prior work demonstrated elevated hematopoietic SRGN levels in HBV-related HCC patients vs. healthy controls, contrasting with reduced SRGN mRNA in HBV-integrated HepG2.215 cells compared to parental HepG2 (27, 28). The gene discussed is SRGN; the disease is hepatocellular carcinoma.